Effects of SGLT2 inhibitor dapagliflozin in patients with type 2 diabetes on skeletal muscle cellular metabolism-Reference-Cited by-同舟云学术

Effects of SGLT2 inhibitor dapagliflozin in patients with type 2 diabetes on skeletal muscle cellular metabolism

Published:2022-12 Issue: Volume:66 Page:101620
ISSN:2212-8778
Container-title:Molecular Metabolism
language:en
Short-container-title:Molecular Metabolism

Author:

op den Kamp Yvo J.M.,Gemmink Anne^ORCID,de Ligt Marlies,Dautzenberg Bas,Kornips Esther,Jorgensen Johanna A.,Schaart Gert,Esterline Russell,Pava Diego A.,Hoeks Joris,Schrauwen-Hinderling Vera B.,Kersten Sander,Havekes Bas,Koves Timothy R.,Muoio Deborah M.,Hesselink Matthijs K.C.,Oscarsson Jan,Phielix Esther,Schrauwen Patrick^ORCID

Funder

AstraZeneca

Maastricht Universitair Medisch Centrum

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference54 articles.

1. Dapagliflozin in patients with chronic kidney disease;Heerspink;The New England Journal of Medicine,2020

2. Dapagliflozin in patients with heart failure and reduced Ejection fraction;McMurray;The New England Journal of Medicine,2019

3. Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin;Bolinder;Diabetes, Obesity and Metabolism,2014

4. Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members;Chen;Diabetes Therapy,2010

5. Differential in vitro effects of SGLT2 inhibitors on mitochondrial oxidative phosphorylation, glucose uptake and Cell Metabolismism;Zugner;International Journal of Molecular Sciences,2022

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diabetes Pharmacotherapy and its effects on the Skeletal Muscle Energy Metabolism;Mini-Reviews in Medicinal Chemistry;2024-09

2. Dapagliflozin improves skeletal muscle insulin sensitivity through SIRT1 activation induced by nutrient deprivation state;Scientific Reports;2024-07-23

3. Sympathetic Activation Promotes Sodium Glucose Co-Transporter-1 Protein Expression in Rodent Skeletal Muscle;Biomedicines;2024-07-01

4. SGLT2 Inhibitor Dapagliflozin Increases Skeletal Muscle and Brain Fatty Acid Uptake in Individuals With Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Positron Emission Tomography Study;Diabetes Care;2024-06-28

5. Recent advances in understanding the mechanisms in skeletal muscle of interaction between exercise and frontline antihyperglycemic drugs;Physiological Reports;2024-06